-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Closing Remarks

Scientific Workshop on Mitochondria and Metabolism in Blood Cancer - From Discovery to Patients
Program: Scientific Workshops
Session: Closing Remarks
Friday, December 6, 2024, 4:55 PM-5:00 PM

Marina Konopleva, MD

Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY

Disclosures: Konopleva: Adaptive: Consultancy; Klondike Biopharma: Research Funding; Janssen: Consultancy, Other: clinical trials; Dark Blue Therapeutics: Membership on an entity's Board of Directors or advisory committees; Intellisphere: Speakers Bureau; MEI Pharma: Consultancy, Membership on an entity's Board of Directors or advisory committees; Novartis: Membership on an entity's Board of Directors or advisory committees; Curis: Consultancy; Auxenion GmbH: Membership on an entity's Board of Directors or advisory committees; Legend Biotech: Membership on an entity's Board of Directors or advisory committees; Menarini Group: Consultancy, Membership on an entity's Board of Directors or advisory committees; AbbVie: Consultancy, Membership on an entity's Board of Directors or advisory committees, Other: clinical trials, Research Funding; Vincerx: Consultancy; Sanofi Aventis: Consultancy; Syndax: Membership on an entity's Board of Directors or advisory committees; Servier: Speakers Bureau.

See more of: Closing Remarks
See more of: Scientific Workshop on Mitochondria and Metabolism in Blood Cancer - From Discovery to Patients
See more of: Scientific Workshops